PT - JOURNAL ARTICLE AU - Michael Riediker AU - Dai-Hua Tsai TI - Estimation of SARS-CoV-2 aerosol emissions from simulated patients with COVID-19 and no to moderate symptoms AID - 10.1101/2020.04.27.20081398 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.27.20081398 4099 - http://medrxiv.org/content/early/2020/06/19/2020.04.27.20081398.short 4100 - http://medrxiv.org/content/early/2020/06/19/2020.04.27.20081398.full AB - Importance Cases of the coronavirus disease 2019 (COVID-19) with no or mild symptoms were reported to frequently transmit the disease even without direct contact. The severe acute respiratory syndrome virus (SARS-COV-2) was found at very high concentrations in swab and sputum of such cases.Objective We aimed to estimate in a mathematical modeling study the virus release from such cases into different aerosol sizes by normal breathing and coughing, and what exposure can result from this in a room shared with such as case.Data Sources and Model We combined the size-distribution of exhaled breath microdroplets for coughing and normal breathing with viral sputum concentrations as approximation for lung lining liquid to obtain an estimate of emitted virus levels. The resulting emission data fed a single-compartment model of airborne concentrations in a room of 50 m3, the size of a small office or medical exam room.Results The estimated viral load in microdroplets emitted by simulated patients while breathing normally was on average 0.0049 copies/cm3 and could go up to 24.5 copies/cm3. The corresponding numbers for coughing simulated patients were 277 copies/cm3 and 1,385,777 /cm3, respectively, per cough. The resulting concentrations in a room with a coughing emitter were always very high, up to 286 million copies/m3. However, also regular breathing microdroplets from high emitters was modelled to lead to several thousand copies/m3.Conclusions and Relevance In this modelling study, breathing and coughing were estimated to release large numbers of viruses, ranging from thousands to billions of virus copies/m3 in a room with an emitter having a high viral load, depending on ventilation and microdroplet formation process. These findings suggest that strict respiratory protection may be needed when there is a chance to be in the same room with a patient - whether symptomatic or not - especially for a prolonged time.Question How much SARS-CoV-2 virus is released from a case by breathing and coughing, and what is the resulting concentration in a room?Finding In this mathematical modelling study, both, breathing and coughing were estimated to release large numbers of viruses, which can lead to billions of virus copies/m3 in a poorly ventilated room with a coughing emitter.Meaning These results may explain the important rate of transmissions and implies the need for strict respiratory protection when people are in the same room with a case with COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis modelling was entirely funded by the Swiss Centre for Occupational and Environmental Health (SCOEH).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This mathematical modelling corresponds to a meta-analysis. We used aggregate data from previous clinical studies in which informed consent had already been obtained by the trial investigators; therefore, our study was exempt from ethics approval, according to the Common Rule.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data sources are mentioned in the manuscript and publicly available.